Waters Corporation $WAT Holdings Decreased by Armstrong Henry H Associates Inc.

Armstrong Henry H Associates Inc. lessened its stake in Waters Corporation (NYSE:WAT) by 47.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,268 shares of the medical instruments supplier’s stock after selling 3,889 shares during the period. Armstrong Henry H Associates Inc.’s holdings in Waters were worth $1,280,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. UMB Bank n.a. boosted its holdings in shares of Waters by 2.8% in the second quarter. UMB Bank n.a. now owns 1,055 shares of the medical instruments supplier’s stock valued at $368,000 after acquiring an additional 29 shares in the last quarter. Integrated Wealth Concepts LLC raised its stake in shares of Waters by 2.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after buying an additional 30 shares in the last quarter. Penserra Capital Management LLC lifted its holdings in shares of Waters by 13.1% in the second quarter. Penserra Capital Management LLC now owns 327 shares of the medical instruments supplier’s stock valued at $114,000 after buying an additional 38 shares during the period. Horizon Investments LLC lifted its holdings in shares of Waters by 5.2% in the first quarter. Horizon Investments LLC now owns 852 shares of the medical instruments supplier’s stock valued at $314,000 after buying an additional 42 shares during the period. Finally, CW Advisors LLC boosted its stake in Waters by 2.0% during the second quarter. CW Advisors LLC now owns 2,112 shares of the medical instruments supplier’s stock valued at $737,000 after buying an additional 42 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Price Performance

Shares of NYSE:WAT opened at $385.31 on Tuesday. Waters Corporation has a 12-month low of $275.05 and a 12-month high of $423.56. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.41. The company has a market cap of $22.94 billion, a P/E ratio of 35.41, a price-to-earnings-growth ratio of 3.50 and a beta of 1.16. The company’s fifty day moving average is $369.47 and its two-hundred day moving average is $333.65.

Waters (NYSE:WAT) last announced its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. Waters had a return on equity of 36.59% and a net margin of 20.89%.The firm had revenue of $608.55 million during the quarter. Equities analysts expect that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have commented on WAT shares. Wells Fargo & Company boosted their price target on shares of Waters from $385.00 to $415.00 and gave the stock an “equal weight” rating in a research report on Monday. TD Cowen boosted their target price on shares of Waters from $345.00 to $390.00 and gave the stock a “hold” rating in a report on Wednesday, November 5th. Weiss Ratings restated a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. Morgan Stanley started coverage on shares of Waters in a research report on Monday, December 1st. They issued an “equal weight” rating and a $423.00 price target on the stock. Finally, JPMorgan Chase & Co. increased their price objective on Waters from $300.00 to $325.00 and gave the company a “neutral” rating in a research report on Thursday, October 9th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, Waters has an average rating of “Moderate Buy” and a consensus target price of $392.19.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.